-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
Chesapeake arranges $1 bln loan to buy back senior notes
On Friday, Shares of Chesapeake Energy Corporation (NYSE:CHK) lost -0.20% to $5.02. During its last trading session, Stock traded with the total exchanged volume of 32.21 million shares. The stock volatility for week was 4.84% while for month was 6.79%.The stock, as of last close, traded 234.67% to its 52 week low and was changed -47.43% from its 52 week high. Chesapeake Energy Corp. The stock’s 50 day moving average is $4.73 and its 200-day moving average is $4.34. Analysts had expected Chesapeake Energy Corporation (NYSE:CHK) to report earnings of about $-0.10 per share on $1,926.64M in revenue.
Advertisement
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. And roundups of analyst notes show that 1 are rating the stock a buy while 1 rate CHK a strong buy. Chesapeake, like most other energy companies, is heavily impacted by a massive plunge in crude oil prices and is trying its utmost to improve its cash balances. The stock’s low price in its 52 week is $1.50 per share while $9.55 as the 52 week high price. Analyst recommendation for this stock stands at 3.20.
While looking at the Stock’s Performance, Chesapeake Energy Corporation now shows a Weekly Performance of 2.66%, where Monthly Performance is 11.56%, Quarterly performance is 23.65%, 6 Months performance is 215.72% and yearly performance percentage is -33.07%. The average numbers of shares are traded in a security per day, during the recent 3-month period. During the last trade, shares reached to high price of $19.34 and touched the low price of $18.73. Stock value has moved between $2.82 – 18.7 in last one year.
Advertisement
Additionally, the company has EPS of -5.37. CRM market capitalization is 55.30B with 19000 employees. Receptos was a public company formed in 2009 with a specific focus on immunology and metabolic disorders that was purchased by Celgene Corporation for $7.8 billion in August 2015. As of December 31, 2014, the Company held an interest in approximately 45,100 gross productive wells, including 33,600 properties in which it held a working interest and 11,500 properties in which it held an overriding royalty interest.